(Q28185857)

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Paraventricular nucleus controls 5-HT2C receptor-mediated corticosterone and prolactin but not oxytocin and penile erection responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Profiles of interaction of R(+)/S(-)-zacopride and anxiolytic agents in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

mCPP-induced anxiety in the light-dark box in rats--a new method for screening anxiolytic activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Norfenfluramine, the fenfluramine metabolite, provides stimulus control: evidence for serotonergic mediation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Possible serotonergic and dopaminergic mediation of the N-ethyl-3,4-methylenedioxyamphetamine discriminative stimulus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Pharmacologic evaluation of the discriminative stimulus of metachlorophenylpiperazine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Serotonin function in anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Discriminative stimulus properties of the serotonin agonist MK 212.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Restricted usefulness of tetraethylammonium and 4-aminopyridine for the characterization of receptor-operated K+-channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Low versus standard dose mCPP challenge in obsessive-compulsive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Modification of the anxiolytic action of 5-HT1A compounds by GABA-benzodiazepine agents in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

The interaction of clozapine with the meta-chlorophenylpiperazine (mCPP) discriminative stimulus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Alteration in 5-hydroxytryptamine agonist-induced behaviour following a corticosterone implant in adult rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Effects of GABA(A) compounds on mCPP drug discrimination in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Effects of ritanserin on ethanol withdrawal-induced anxiety in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Behavioral and neuroendocrine responses to m-chlorophenylpiperazine in subtypes of alcoholics and in healthy comparison subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Anger and anxiety responses to m-chlorophenylpiperazine in generalized anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dosage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT(2C) receptors but not 5-HT(2A) or 5-HT(2B) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Neurochemical effects of 5-HT1 receptor ligands in pigeons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Discriminative stimulus properties of eltoprazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Discriminative stimulus properties of mCPP and alprazolam are not mediated by anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

The elevated T-maze as an experimental model of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Role of 5-HT in stress, anxiety, and depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Characterization of the ethanol-like discriminative stimulus effects of 5-HT receptor agonists as a function of ethanol training dose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Behavioural and pharmacological characterisation of the canopy stretched attend posture test as a model of anxiety in mice and rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Ritanserin facilitates anxiety in a simulated public-speaking paradigm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Further investigations of the serotonergic properties of the ibogaine-induced discriminative stimulus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Sex differences in the discriminative stimulus effects of m-chlorophenylpiperazine and ethanol withdrawal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

m-Chlorophenylpiperazine as a probe of serotonin function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

High social anxiety and low aggression in Fawn-Hooded rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Specificity of ethanollike effects elicited by serotonergic and noradrenergic mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Inverse agonist properties of the THBC discriminative stimulus: Asymmetrical generalization with FG 7142

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotonergic anxiolytics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Ethanol blocks cytosolic Ca2+ responses triggered by activation of GABA(A) receptor/Cl- channels in cultured proliferating rat neuroepithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

TFMPP may produce its stimulus effects via a 5-HT1B mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Full substitution of the discriminative cue of a 5-HT(1A/1B/2C) agonist with the combined administration of a 5-HT(1B/2C) and a 5-HT(1A) agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Role of 5-HT2A and 5-HT2C receptor subtypes in the two types of fear generated by the elevated T-maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Discriminative stimulus properties of eltoprazine in the pigeon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Serotonin releasing agents. Neurochemical, therapeutic and adverse effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Psychomotor slowing, neuroendocrine responses, and behavioral changes after oral administration of meta-chlorophenylpiperazine in normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Tetrahydro-beta-carboline may produce its stimulus effects via 5HT1B receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

The 5-HT3 antagonist, BRL 46470 does not attenuate m-chlorophenylpiperazine (mCPP)-induced changes in human volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Are 5-HT2 antagonists endowed with anxiolytic properties in rodents?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

The subjective effects of MDMA and mCPP in moderate MDMA users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

A discriminative stimulus produced by 1-(3-chlorophenyl)-piperazine (mCPP) as a putative animal model of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Discriminative stimulus properties of m-chlorophenylpiperazine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

A comparison of the behavioural effects of 5-HT2A and 5-HT2C receptor agonists in the pigeon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Cocaine depresses GABAA current of hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Cocaine and lidocaine have additive inhibitory effects on the GABAA current of acutely dissociated hippocampal pyramidal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900422-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(03)00422-3

0 references

Fatcat ID

release_ystpmhnxkjhvzgm5bij4uekesy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ystpmhnxkjhvzgm5bij4uekesy